OptimizeRx (OPRX) Stock Price

The business model of OPTIMIZERx Corp is focused on providing software solutions and technology platforms to the healthcare industry. The company offers a comprehensive suite of services, including electronic prescribing for healthcare providers, patient engagement and adherence tools, as well as financial assistance programs for patients to help them access and afford medication. OPTIMIZERx Corp's innovative technology enables pharmaceutical manufacturers to effectively engage with healthcare professionals and patients, improving patient outcomes and reducing healthcare costs. With its unique offerings and solutions, OPTIMIZERx Corp aims to optimize the connection between patients, healthcare providers, and pharmaceutical companies in the healthcare ecosystem.

OPTIMIZERx Corp is primarily active in the healthcare and pharmaceutical industries.

OPTIMIZERx Corp is a renowned digital health company that specializes in providing software solutions to streamline the pharmaceutical industry. Founded in 2006, OPTIMIZERx has established itself as a leader in the field, offering innovative platforms to enhance patient engagement and adherence. With a focus on improving communication between healthcare providers, pharmaceutical companies, and patients, OPTIMIZERx's solutions enable physicians to deliver cost-effective and personalized care. The company has consistently grown its presence by incorporating cutting-edge technologies and strategic partnerships, ensuring it stays at the forefront of the industry. OPTIMIZERx Corp's commitment to improving patient outcomes has made it a trusted name in the digital health sector.

OPTIMIZERx Corp, a leading provider of digital health communication solutions, has achieved several significant milestones. The company experienced impressive revenue growth, surpassing $30 million in annual revenue in 2020. In addition, OPTIMIZERx Corp expanded its client base, forging partnerships with renowned pharmaceutical manufacturers, healthcare providers, and pharmacies. The company launched innovative solutions, such as its SampleRx platform, which allows patients to access cost-saving coupons and trial offers for prescription medications. OPTIMIZERx Corp also made strategic acquisitions, augmenting its capabilities and expanding its market reach. These milestones demonstrate the company's commitment to revolutionizing patient engagement and improving prescription affordability in the healthcare industry.

OPTIMIZERx Corp is primarily present in the United States.

Optimizerx Corp represents values of innovation, collaboration, and customer-centricity. With a strong corporate philosophy focused on improving patient access to life-saving therapies, Optimizerx Corp aims to enhance the healthcare ecosystem through its digital platform and strategic partnerships. Committed to delivering superior solutions and services, the company leverages cutting-edge technology and data-driven insights to empower patients, healthcare providers, and pharmaceutical manufacturers. Optimizerx Corp strives to optimize the healthcare experience, driving better outcomes, cost-savings, and improved patient adherence. As a trusted leader in the industry, Optimizerx Corp demonstrates a dedication to excellence, integrity, and creating value for its shareholders, healthcare partners, and the overall community.

Analysts currently set an average price target of 10.25 USD for the OptimizeRx stock (median: 11.00 USD), implying +4.4 % versus the latest price. The consensus is based on 12 analyst ratings.

OptimizeRx Analyst Price Targets 2026

12 analysts currently rate the OptimizeRx stock: 11 recommend buying, 1 holding and 0 selling. For 2026, analysts expect OptimizeRx to generate revenue of 96.23 M USD and earnings per share of 0.84 USD.

OptimizeRx Analyst Price Targets 2026

Converted at the current exchange rate, the OptimizeRx share trades at 8.74 EUR (9.82 USD).

The OptimizeRx share (OPRX) is listed on 1 stock exchanges, including: NASDAQ (OPRX).

The OPTIMIZERx Corp is a leading provider of digital solutions to improve patient communication, adherence, and access to medications. The company is headquartered in Rochester, Michigan and works with numerous pharmaceutical manufacturers, insurers, and pharmacies to optimize healthcare. One of OPTIMIZERx's main products is the Sample Fulfillment System (SFS), a paperless system for ordering and delivering medication samples to doctors. Doctors can access a wide range of medications, order samples, and effectively treat their patients through the system. The SFS is easy to use and provides doctors with a convenient way to receive medications and care for patients. OPTIMIZERx also offers a variety of patient communication solutions to improve compliance and adherence. The OPTIMIZERx portal is an online portal that allows patients to order and manage medications, as well as receive information about their medications and their side effects. The portal is user-friendly and easy to navigate, allowing patients to securely access their medical information. Another important area of OPTIMIZERx is supporting patients with coupons and discounts on prescription medications. OPTIMIZERx offers discount programs for a variety of medications to help patients manage the high costs of their medications. Similarly, OPTIMIZERx offers various options to assist patients in applying for discounts and ensuring they receive the best offer. In addition, OPTIMIZERx also provides communication solutions for pharmacies to improve information exchange and collaboration between pharmacies and doctors. The OPTIMIZERx eCoupon system allows pharmacies to pass on discounts and coupons directly to patients. In summary, the OPTIMIZERx Corp offers a wide range of digital solutions to improve patient communication, increase adherence and compliance, and facilitate access to medications. The company works closely with pharmaceutical manufacturers and other healthcare providers to optimize healthcare and provide the best possible support for patients.

The expected revenue of OptimizeRx is 96.23 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of OptimizeRx is 16.33 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of OptimizeRx is currently 11.66. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the OptimizeRx stock.

The price-to-sales ratio (P/S) of OptimizeRx is currently 1.98. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the OptimizeRx stock.

The Eulerpool Quality Score for OptimizeRx is 5/10.

The ISIN of OptimizeRx is US68401U2042. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of OptimizeRx is A2JL4Z. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of OptimizeRx is OPRX. The ticker symbol is used to trade OptimizeRx shares on the stock exchange.